Professional
Added to YB: 2025-05-23
Pitch date: 2025-05-21
CRL [neutral]
Charles River Laboratories International, Inc.
+44.28%
current return
Author Info
Pernas Research is a former CIO of a $3.5B fund that now share actionable stock research. Sign up for the newsletter.
Company Info
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally.
Market Cap
$7.0B
Pitch Price
$133.79
Price Target
N/A
Dividend
N/A
EV/EBITDA
10.22
P/E
-232.20
EV/Sales
2.45
Sector
Life Sciences Tools and Services
Category
special_situation
Pernas Research More Research Needed On: Charles River Laboratories International, Inc.
CRL MORE RESEARCH NEEDED: Leading preclinical/clinical lab services provider. 21K+ employees across 21 countries. 'Rat King' shares down 30% on FDA no longer requiring animal testing, pushing organoids instead. Near-term impact minimal as organoids can't match organ complexity. Long-term implications unclear.
Read full article (1 min)